ZV

Zephyr Venture Partners

North America, British Columbia, Canada, Vancouver

Description

Biotech/pharma/healthcare

Investor Profile

Zephyr Venture Partners has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Pre Seed (50%)
  • Convertible Note (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Sales
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zephyr Venture Partners frequently co-invest with?

Natural Capital
North America, California, United States, Palo Alto
Co-Investments: 1
FAST — by GETTYLAB
North America, California, United States, San Francisco
Co-Investments: 1
Helios Capital
North America, New York, United States, New York
Co-Investments: 1
Sand Hill Angels
North America, California, United States, Mountain View
Co-Investments: 1
Plum Alley
North America, New York, United States, New York
Co-Investments: 1
Tribe Capital
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Zephyr Venture Partners often collaborate with?

PD
North America, California, United States, Menlo Park
Shared Deals: 1
AM
North America, California, United States, San Francisco
Shared Deals: 1
KA
North America, California, United States, San Francisco
Shared Deals: 1
BG
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
SD
North America, California, United States, San Francisco
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Zephyr Venture Partners?

Default

San Francisco, California, United States

Default is an all-in-one inbound lead qualification, scheduling, & routing platform.

Sales
Pre SeedOct 1, 2021
Amount Raised: $700,000
Ashvattha Therapeutics

Redwood City, California, United States

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Convertible NoteMay 31, 2020
Amount Raised: $22,000,000